ABSTRACT Experimental inoculation of commercial laying hens, maintained under controlled conditions, with the S6-strain of Mycoplasma gallisepticum (S6MG) at 10 wk of age has previously been shown to affect the lengths and weights of various portions of the reproductive tract without affecting subsequent performance. Two trials were conducted to compare the effects of S6MG inoculation at 10 wk of age (prior to lay), 22 wk of age (onset of lay), and 45 wk of age (during lay) on performance characteristics in commercial layers housed and maintained under controlled conditions, as in previous studies. In each trial, BW, mortality, egg production, egg weight, eggshell weight per unit of surface area, percent-
INTRODUCTION
Mycoplasma gallisepticum (MG) strains vary in virulence, tissue tropism, and antigenic makeup. Different antigenic profiles of MG are due to the differential expressivities of major surface antigens (Garcia et al., 1994) . The severities of the MG infection symptoms depend on such factors as environmental conditions, ammonia concentration in the air, stress, the presence of other pathogenic factors, and the breed of the animal (Sato et al., 1972; Zander, 1984; Mohammed et al., 1987b) . The most common symptoms of MG infection in adult chickens include swollen sinuses and serous exudates in the nostrils (Grimes and Rosenfeld, 1972; Ley and Yoder, 1997) . Furthermore, Burnham et al. (2002a) reported that egg production and the 1 This is Journal Article Number J-10665 from the Mississippi Agricultural and Forestry Experiment Station supported by MIS-321010. 2 Use of trade names in this publication does not imply endorsement by Mississippi Agricultural and Forestry Experiment Station of these products nor of similar ones not mentioned. 3 To whom correspondence should be addressed: dpeebles@ poultry.msstate.edu.
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age eggshell weight, percentage albumen weight, percentage yolk weight, and yolk weight per albumen weight ratio were examined at various ages throughout an entire laying cycle. Across wk 47 and 58 (age periods after the last 45 wk inoculation), eggshell weight per unit of surface area and percentage eggshell weight were significantly reduced in birds that had received an S6MG inoculation at 45 wk of age when compared with birds that had not received an S6MG inoculation or had been inoculated with S6MG at either 10 or 22 wk of age. Alterations in eggshell quality in response to S6MG may become evident only in older birds that are experiencing declines in production when housed under controlled conditions. egg characteristics of layers inoculated with the F-strain of MG at 12 wk of age were significantly different from uninoculated controls. More specifically, initiation of lay was delayed 1 wk, and weekly egg production after 42 wk of age and overall average weekly egg production were reduced in laying hens inoculated with F-strain MG at 12 wk of age.
The S6-strain of MG (S6MG) is considered one of the more virulent strains in the field (Levisohn et al., 1986) . Deterioration in egg quality has been noted due to infection of the genital tract of chickens inoculated via the yolk sac with S6MG. In that study, 25% of the chickens had gross lesions of the oviduct, whereas 81% displayed microscopic lesions that were found throughout all parts of the oviduct (Pruthi and Kharole, 1981) . When S6MG was directly injected into the air sacs of specific-pathogenfree chickens, lesions were present in up to 90% of the experimental population (Lam et al., 1984) . Nunoya et al. (1997) reported that S6MG infection caused salpingitis and a 3 to 4% decrease in monthly egg production in layers at 8.5 mo of age while housed in a commercial facility. However, a recent study showed that under controlled conditions, S6MG inoculation at 10 wk of age produced no deleterious effect on egg production or egg quality (Parker et al., 2002) .
Because low level MG infections can become exacerbated by the onset and increased rate of egg production (Yoder, 1991) , it is important to follow birds over an entire laying cycle. The objective of the current study was to compare the effects of S6MG inoculation on various performance characteristics, including eggshell and internal egg quality, at 3 different age periods throughout a complete egg-laying cycle in commercial layers. The 3 age periods at which birds were inoculated were prior to lay (10 wk of age), at onset of lay (22 wk of age), and during lay (45 wk of age). In this study, a controlled or ideal environment (limited exposure to bacteria and control of temperature, humidity, and lighting) as described by Parker et al. (2002) , was chosen. A controlled environment was used to reduce or remove as many environmental stressors as possible so as to more accurately assess the true impact of the organism itself. Determinations and comparisons of these effects may provide vital information as to the relative impact of these regimens on performance and the age-related physiological changes that the layer undergoes in response to an S6MG challenge.
MATERIALS AND METHODS

Pullet Housing and Management
Two individual trials were conducted in this study (experiment was repeated twice). In both trials, 1-d-old Single Comb White Leghorn pullets of a single genetic strain (Hy-Line Variety W-36) were obtained from a commercial source that was monitored and certified free of MG and Mycoplasma synoviae (MS; National Poultry Improvement Plan and Auxiliary Provisions, 2003) . The layer strain used in this study was the same as that used by Burnham et al. (2002a Burnham et al. ( ,b, 2003 . Chicks were vaccinated at 10 d of age for infectious bursal disease via the drinking water. At 12 d and again at 4 wk of age, chicks were vaccinated for Newcastle disease and infectious bronchitis by the same route. At 9 wk of age in trial 1 and at 6 wk of age in trial 2, 10 randomly selected pullets were bled from the left cutanea ulnea wing vein and tested for antibodies to MG and MS using the serum plate agglutination (SPA) and the hemagglutination-inhibition (HI) tests . At those times, swabs were also collected from the choanal cleft (Branton et al., 1984) and placed into tubes containing Frey's broth (Papageorgiou medium; Frey et al., 1968) supplemented with 0.15 mg of thallium acetate and 10 6 IU of penicillin-G/mL. Tubes were incubated at 37°C for 30 d or until a phenol red indicator reaction occurred in the medium, indicating growth. Media samples from tubes that showed growth were inoculated onto Frey's agar and incubated at 37°C. Colonies with morphology suggestive of Mycoplasma species were examined by an agar plate fluorescent antibody (FA) method (Baas and Jasper, 1972 ) that used direct labeling of colonies stained with anti-MG polyclonal antibodies produced in rabbits and labeled with fluorescein isothiocyanate (Kleven, 1981) . Until the pullets were 10 wk of age, they were raised on clean dry litter in a 5.5 × 6.1 m section of a conventional poultry house at the USDA-ARS-Poultry Research Unit, resulting in an initial flock density of 0.034 m 2 /bird. A daily artificial lighting schedule followed a 13L:11D cycle. One 75-W incandescent light bulb was used to illuminate each 8.4 m 2 of floor space, providing a calculated intensity of 35.5 lx at bird level. At 10 wk of age, 11 pullets were randomly assigned to each of 16 (total of 176 pullets) negative-pressure fiberglass biological isolation units (1.16 m 2 ). The units were housed in a previously described poultry disease isolation facility at the same USDA research laboratory (Branton and Simmons, 1992) . All birds were wing-banded for purposes of identification and individual data collection. The temperature inside each biological unit was maintained at 25°C.
Layer Housing and Management
Hen numbers in each treatment replicate unit were reduced to 10 per unit (total of 160 pullets) at point of lay (18 wk of age) so that bird density was 0.116 m 2 /bird for the duration of the trial. Of the 16 total units, 4 replicate units served as sham-inoculated controls throughout the study. Of the 12 other units, 4 replicate units were sequentially assigned to 1 of 3 inoculation treatment groups at the time of inoculation (treatment) so that by wk 45 (last treatment period) of each trial, 4 replicate units were assigned to each of 4 treatments with each treatment represented by 1 row of 4 units. More specifically, until the time at which birds in a set of 4 replicate units from a single row were treated (inoculated), they were included as control replicates. Four replicate units received S6MG inoculation at 10 wk of age, and 12 replicate units were designated as sham-inoculated controls from wk 10 through 21. Four of the 12 control units then received S6MG inoculation at 22 wk of age, and 8 replicate units remained as controls from wk 22 through 44. Four of the 8 control units received S6MG at 45 wk of age, and 4 replicate units remained as controls from wk 45 through the end of each trial. In trial 2, the location of treatments within the isolation facility was different from that in trial 1 to assure environmental randomization between trials. Beginning at 18 wk of age, the duration of the artificial lighting schedule was increased 15 min/d until a cycle of 16 h 15 min of light per 7 h 45 min of dark was achieved in trial 1, and a cycle of 17 h 15 min of light per 6 h 45 min of dark was achieved in trial 2. These artificial lighting programs were maintained through the end of both trials.
Pullet and Layer Diets
For the entirety of each trial, chickens had ad libitum access to feed and water. Diets in both trials were formulated according to the age of the birds and included the following: starter (0 to 6 wk), grower (7 to 12 wk), developer (13 to 18 wk), prelay (18 to 19 wk), and layer (20 to 60 wk). All diets were formulated to meet or exceed National Research Council (1994) specifications. Ingredient percentages and calculated and determined analyses of these diets were as described by Burnham et al. (2002a) . In both trials, CP and lysine percentages in the layer diet were adjusted according to the percentage of feed consumed per bird every 28 d until trial termination. No medication was administered during the study. At 54 wk of age in trial 2, feed and fecal samples (Tables 1 and 2 , respectively) were analyzed for determined moisture, ash, CP, crude fat, crude fiber, total nitrogen, total digestible nitrogen, and fatty acid concentrations for comparative purposes to estimate differences in the absorption of these dietary components between treatments. Feed samples were obtained by mixing 5 samples from 3 depths (2 on the top, 1 in the middle, and 2 at the bottom) within a common feed container. The mixed samples from each of 2 containers, used for feeding all of the birds in the study, were pooled and thoroughly mixed prior to analysis. Fecal samples were collected by placing a foil tray under the floor grate within each unit for 24 h. Fecal samples collected from replicate units belonging to the same treatment group were pooled and thoroughly mixed prior to analysis. The pooled samples were stored at −20°C for later analysis. Fresh, pooled fecal samples were analyzed immediately after collection. All determined analyses were performed according to the methods of the Association of Official Analytical Chemists (1980) . 4 University of Georgia, Athens, GA.
S6MG Inoculation and Mycoplasma Detection
Pullets treated with S6MG were inoculated via eye drop in the right eye with 0.04 mL of a 24-h Frey's broth culture of high-passage S6MG at 10, 22, or 45 wk of age. Mycoplasma gallisepticum organisms were advanced after being received from S. H. Kleven 4 at the 212th passage. This S6MG strain was tested by a tracheal ring organ culture model as described by Cherry and Taylor-Robinson (1970) and was shown to significantly reduce ciliary activity within 5 d. Titers and passages of the inocula are presented in Table 3 . Similarly, pullets designated as controls were sham-inoculated via eye drop in the right eye at 10 wk of age with 0.04 mL of sterile Frey's broth medium. At 60 wk of age in both trials, one randomly selected hen from each replicate unit in each of the 4 treatment groups was bled and swabbed. Each of these samples was tested for the presence of Mycoplasma species as previously described for pullets at 9 wk of age in trial 1 and at 6 wk of age in trial 2.
Data Collection
Individual BW of all hens in each unit was recorded at 20, 24, 32, 43, 47, and 58 wk of age in both trials. Mortality and egg production were recorded daily and analyzed weekly between wk 21 and 57 in both trials. Mortality was expressed as a percentage of the total number of birds in each unit, and egg production was expressed as percentage hen-day production. Egg weight (EW; g) was determined weekly from 22 through 57 wk of age in both trials.
At wk 24, 32, 43, 47, and 58 in both trials, EW (g), eggshell weight per unit of surface area (SWUSA; mg/ cm 2 ), and percent eggshell weight (PSW; %), albumen weight (PAW; %), yolk weight (PYW; %), and yolk weight / albumen weight ratio (YAR) were determined. The determination of EW in those eggs used specifically for egg and eggshell quality determinations was for the purposes of calculating eggshell surface area and relative egg component weights. For determination of all of the above egg parameters, at least 10 eggs were collected from each replicate unit for an accurate estimate of each parameter (Buss, 1984) . If less than 10 eggs were collected on a given day, more were collected the following day of the same week. Nevertheless, determinations were made on the same day that eggs were collected. Eggshell weight per unit of surface area (SA) was determined using the following formula: SWUSA = [eggshell weight (mg) / SA (cm 2 )], where SA = 3.9782 × EW 0.7056 (Carter, 1975) . Eggshell weight was determined according to the procedure described by Brake et al. (1984) . Egg yolk (fresh), albumen (fresh), and shell (dried shell plus membranes) weights were expressed as percentages of EW.
Statistical Analysis
A completely randomized experimental design was used. Data prior to wk 22 (first age interval), from wk 22 through 44 (second age interval), and from wk 45 through trial termination (third age interval) were analyzed separately. The data of both trials were analyzed together. Trial was taken to be a random effect, and all data within each of the 3 age periods were subjected to a repeated measures analysis. In the first age period, the controls and the group inoculated at 10 wk with S6MG were compared. In the second age period the controls and groups inoculated with S6MG at 10 and 22 wk were compared. In the third age period, the controls and groups inoculated with S6MG at 10, 22, and 45 wk were compared. Individual sample data within each replicate unit were averaged prior to analysis. The results from trials 1 and 2 were not reported independently but were reported over both trials. Least-squares means were compared in the event of significant global effects (Steel and Torrie, 1980) . All data were analyzed using the MIXED procedure of SAS software (2000) . Statements of significance were based on P ≤ 0.05 unless otherwise stated.
RESULTS
All initial mycoplasmal cultures as well as SPA and HI test results obtained from pullets at 9 wk of age in trial 1 and at 6 wk of age in trial 2 were negative for MG and MS. Serum samples obtained from control birds at 60 wk of age in both trials were SPA and HI negative for MG, whereas the same tests were positive for MG in the S6MG-inoculated hens. Hens were considered MG-free when they exhibited no detectable HI titers. All S6MG-inoculated hens tested had HI titers ≥1:80 (geometric mean of 80.0). Similarly, FA culture results for swabs obtained at 60 wk of age in both trials were negative for Mycoplasma species growth for all control hens tested, whereas all S6MG-inoculated hens tested were MG positive (positive for MG fluorescence) and MS negative (negative for MS fluorescence). The fecal compositions of the birds from the 4 treatment groups were not statistically compared. However, the ME, CP, crude fat, and total nitrogen content of the feces from birds inoculated with S6MG at 22 wk were visibly lower than controls, whereas the fecal nutrient levels among the control, 10 wk S6MG, and 45 wk S6MG groups were comparable. Because birds in all 4 treatments received the same dietary nutrients, the fecal analysis in Table 2 suggests that the 22 wk S6MG inoculation increased nutrient absorption over that in control birds. At wk 20, 24, 32, 43, 47, and 58, mean BW (g) ± SEM was 1,331 ± 42.0, 1,351 ± 30.0, 1,380 ± 30.0, 1,441 ± 30.0, 1,481 ± 33.9, and 1,534 ± 33.9, respectively. However, Table 4 . Weekly egg production across treatment from wk 22 through 44 (second age interval) and from wk 45 through 57 (third age interval) in trials 1 and 2
Age
Egg production Age Egg production (wk; second age interval) (% hen-day) (wk; third age interval) (% hen-day) Means among ages within the 22-to 44-wk period with no common superscript differ significantly (P ≤ 0.05).
a-d
Means among ages within the 45-to 57-wk period with no common superscript differ significantly (P ≤ 0.05). within each of the age intervals examined [prior to wk 22 (first age interval), from 22 through 44 wk of age (second age interval) and from 45 wk of age through trial termination (third age interval)], there were no significant effects due to bird age or inoculation treatment on bird mortality or BW. Also, egg production in the 3 age intervals investigated was not affected by inoculation treatment. However, there were significant age main effects on weekly egg production in the second (P ≤ 0.001) and third (P ≤ 0.04) age intervals (Table 4 ). In the second age interval, egg production increased significantly between 22 and 23 wk of age. Furthermore, egg production did not decrease significantly from its peak at wk 28 until wk 36, which was followed by another significant decrease by wk 44. In the third age interval, egg production was highest at wk 45, and subsequently underwent significant consecutive decreases at wk 50 and 57.
There were significant interactions of bird age by treatment for EW in the second (P ≤ 0.006) and third (P ≤ 0.03) age intervals. Highly significant (P ≤ 0.0001) differences existed among weeks within all treatment groups in both age intervals, but no significant differences were found among treatment groups at each of the weeks within both age intervals. In the second age interval, there were no significant bird age or inoculation treatment effects on SWUSA, PSW, or PYW. Also, in the third age interval, there were no bird age or inoculation treatment effects on PAW, PYW, or YAR. However, there were significant main effects due to bird age for PAW (P ≤ 0.01) and YAR (P ≤ 0.04) in the second age interval, and there were significant treatment main effects for SWUSA (P ≤ 0.02) and PSW (P ≤ 0.03) in the third age interval. In the second age interval, PAW was significantly lower at 43 wk of age compared with that at 32 and 24 wk of age, but PAW at wk 32 and 24 were not significantly different from each other (Table 5 ). Conversely, YAR was significantly higher at wk 43 compared with that at wk 24, with YAR at 32 wk of age being intermediate (Table 5 ). In the third age interval, SWUSA and PSW were significantly reduced in birds that had received an S6MG inoculation at 45 wk of age when compared with birds that had not received an S6MG inoculation or were inoculated with S6MG at 10 or 22 wk of age (Table 6 ).
DISCUSSION
At the end (60 wk of age in both trials) of this study, SPA, HI, and FA tests verified systemic infections in Table 5 . Percentage albumen weight (PAW) and yolk weight to albumen weight ratio (YAR) across treatment at 24, 32, and 43 wk of age (second age interval) in trials 1 and 2 1 Age PAW (wk; second age interval) Means among ages within each parameter column with no common superscript differ significantly (P ≤ 0.05).
1 SEM based on pooled estimate of variance. Means among treatments within each parameter column with no common superscript differ significantly (P ≤ 0.05).
1 SEM based on pooled estimate of variance.
S6MG-inoculated birds. Conversely, sham-inoculated birds remained S6MG-free throughout the study. Many investigators have reported the effects of field and vaccine strain infections of MG in birds ( Van der Heide, 1977; Gentry, 1978; Carpenter et al., 1981; Lin and Kleven, 1982; Hildebrand et al., 1983; Glisson et al., 1984; Yoder et al., 1984; Branton and Deaton, 1985; Khan et al., 1986; Mohammed et al., 1987a,b; Stadelman, 1988; Kleven et al., 1990; Patterson, 1994; Burnham et al., 2002a,b; Parker et al., 2002; Burnham et al., 2003; Parker et al., 2003; Peebles et al., 2004) . Manifestations of MG usually occur in the respiratory system, and lesions become extensive when complicated by other bacteria. There is a marked interaction among Mycoplasma, respiratory viruses, and bacteria (Saif et al., 1970; Jordan, 1972; Springer et al., 1974; Stipkovits, 1979; Rhoades, 1981; Gross, 1990; Patterson, 1994; Kleven, 1998b) .
Environmental factors such as dust and ammonia, along with intensive rearing or stress, crowding, cold weather, live virus vaccination, or natural virus infection may also be important in lesion incidence and severity (Jordan, 1972; Springer et al., 1974; Jordan, 1985) . However, when there are no secondary infections to mycoplasmas, infection is often subclinical or mild (Kerr and Olson, 1967) . The birds in this study were housed in biological isolation units, from 10 wk of age through the remainder of the study, where they remained free of natural infections and other environmental stressors common in commercial operations. As a result, the S6MG-infected hens exhibited no outward pathological symptoms. Furthermore, S6MG inoculation treatment had no significant effect on the mortality or BW of the hens. Burnham et al. (2002a) showed that onset of lay was delayed approximately 1 wk, and that weekly egg production after 42 wk of age and overall average weekly egg production were reduced in laying hens housed in biological isolation units and inoculated with F-strain MG at 12 wk of age. It was also noted that the percentage of undersized eggs laid by F-strain MG-inoculated birds was significantly lower at 19 wk of age but was higher at 20 and 21 wk of age when compared with controls, and that PSW at 24 and 34 wk of age was significantly higher in F-strain MG-inoculated birds when compared with controls. Burnham et al. (2002b) suggested that alterations in the performance and egg characteristics of layers inoculated with F-strain MG at 12 wk of age are related to mutual functional disturbances in the liver, ovary, and oviduct without concomitant intestinal changes. This suggestion was supported by results showing a reduction in ripe ovarian follicles, ovarian follicle size, and magnal, isthmal, and vaginal proportions along with increased incidences of fatty liver hemorrhagic syndrome in birds subsequent to inoculation with F-strain MG at 12 wk of age.
It has been proposed by Williams and Sharp (1978) and Palmer and Bahr (1992) that decreases in egg production (% hen/d) with hen age is in part caused by an increase in the incidence of atresia and a reduction in the number of follicles that reach the final phase of rapid growth. Ovarian regression may be related to retarded production (liver), transport (blood), and/or uptake (ovary) of yolk particles. Decreases in plasma protein and serum triglyceride concentrations may lead to ovarian follicular regression, atrophic reproductive tissues, and higher incidences of fatty livers during the egg-laying cycle. Burnham et al., (2003) have reported decreases in yolk lipid and yolk cholesterol between 22 and 28 wk of age in birds inoculated with F-strain MG. In addition, decreases in overall yolk myristic, palmitoleic, and oleic acid percentages along with increases in yolk linoleic, stearic, and arachidonic acid percentages have been reported for F-strain MG-inoculated birds (Burnham et al., 2003) . Recent findings showing that MG has the ability to invade cells (Winner et al., 2000) suggests that MG may be capable of interfering with liver lipid metabolism. Reductions in feed efficiency in MG-infected birds have also been reported (Domermuth et al., 1967; Rodriquez and Kleven, 1980; Patterson, 1994) . Furthermore, Winner et al. (2000) demonstrated that MG has the capability of passing through the mucosal barrier to cause systemic infections, and Mycoplasma species may be cultured from the avian liver (Sahu and Olson, 1976) . Therefore, the active infection may cause the livers of birds infected with MG to react similarly to that of inefficient or aging hens earlier in the reproductive cycle.
However, Parker et al. (2002) showed that 10 wk S6MG inoculations of commercial layers housed similarly to those by Burnham et al. (2002a,b) had no effect on BW, egg production, EW, associated internal egg and eggshell quality parameters, or histopathologic lesion scores. In a subsequent report (Peebles et al., 2004) , the leukocyte profiles of the same birds used by Parker et al. (2002) were shown not to be affected by the S6MG inoculation at 10 wk. Parker et al. (2003) also noted that the inoculation of commercial layer hens at 20 wk of age had no effect on BW, egg production, digestive tract weight and length, or histopathologic lesion score. Nevertheless, significant differences were noted in the lengths and weights of various portions of the reproductive tract due to the inoculation of S6MG at 20 wk of age (Parker et al., 2003) . The effects of the S6MG included decreased oviduct, infundibulum, and magnum length, and decreased uterus weight. Conversely, vagina weight was increased in the S6MG-treated birds (Parker et al., 2003) . Similar to the findings of Parker et al. (2002 Parker et al. ( , 2003 , S6MG inoculation at 10 and 22 wk of age had no effect on BW, egg production, EW, or on the internal egg and eggshell quality parameters investigated in the present study. Fecal analysis suggested that the S6MG inoculation at 22 wk might have increased dietary nutrient absorption and resulted from increased energy demands associated with an FMG inoculation that is proximate to initiation of lay. However, because inoculation treatment effects were limited to SWUSA and PSW and did not involve the 22 wk S6MG-inoculated group of birds, layer performance was not influenced by effects that the 22 wk S6MG inoculation might have had on nutrient absorption. The virulence of the infecting strain of MG may critically influence its observed effects. Therefore, because S6MG is considered to be one of the more virulent isolated strains (Levisohn et al., 1986) , the fewer observed effects caused by S6MG in this and previous studies in comparison with those previously reported for F-strain MG were unexpected. Nevertheless, these data suggest that birds housed in a controlled environment that have been infected with Fstrain MG prelay may be more susceptible to age-related disturbances in productivity than are those similarly infected with S6MG.
Although S6MG inoculation during lay (22 and 45 wk of age) may have altered the characteristics of the reproductive tracts of the birds in this study, as suggested by the findings of Parker et al. (2003) , only the inoculation at 45 wk ultimately caused significant reductions in eggshell quality, as evidenced through decreases in both SWUSA and PSW. Perhaps the birds in the current trials were better able to adapt to an S6MG infection when inoculated prior to or at the onset of lay rather than late in lay. In addition, reproductive tract alterations in response to S6MG may become apparent through changes in eggshell quality only in older birds that are experiencing declines in production when housed under ideal conditions. However, because these birds were housed in biological isolation units, these results do not preclude the possibility that additional performance parameters may be affected throughout an entire laying cycle in birds infected with S6MG before and during lay that are housed in facilities where there are increased levels of environmental stress.
